Vetoquinol SA

Report Publication Announcement • Dec 12, 2016

Press Release Lure (France), December 12, 2016

2017 CALENDAR OF FINANCIAL COMMUNICATION

December 12, 2016 (Lure, France) – Vetoquinol published its calendar of financial communication for 2017.

January 26, 2017	2016 Annual revenues (after market)
March 23, 2017	2016 Annual results (before market)
April 13, 2017	2017 First quarter revenues (after market)
May 30, 2017	Annual shareholders' meeting
June 6, 2017	Dividend distribution
July 27, 2017	2017 Interim revenues and interim results (after market)
October 17, 2017	2017 Third quarter revenues (after market)
January 23, 2018	2017 Annual revenues (after market)

Next update: 2016 Annual revenues – January 23, 2017 after market close

About Vetoquinol

Vetoquinol is a leading global player in the animal health sector serving both the livestock (cattle and pigs) and pet (dogs and cats) markets.

An independent pure player, Vetoquinol designs, develops and sells veterinary drugs and non-medicinal products in Europe, the Americas and the Asia Pacific region.

Since its foundation in 1933, Vetoquinol has pursued a strategy combining innovation with geographical diversification. The Group's hybrid growth is driven by the reinforcement of its product portfolio coupled with acquisitions in high potential growth markets. Vetoquinol employs over 2,000 people. Vetoquinol has been listed on NYSE Euronext Paris since 2006 (symbol: VETO).

At the 2016 Gaia-Index, best small to medium-sized companies for its commitment to Environmental, Social and Corporate Governance (ESG).

For further information, go to: www.vetoquinol.com.

For any information, contact:

VETOQUINOL KEIMA COMMUNICATION Investor Relations Marie-Josée Aubry-Rota Tel: +33 (0)3 84 62 59 88 relations.investisseurs@vetoquinol.com

Investor & Media Relations Emmanuel Dovergne Tel: +33 (0)1 56 43 44 63 emmanuel.dovergne@keima.fr